Skip to content
10-Q

Quarterly Report

NxStage Medical, Inc.

0001333170-18-000004

← back to feed
Filed
May 10, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 4, 2018 66.5M sh
Capex Q1 2018 · Mar 31, 2018 $1.09M
Capex Q1 2018 · Mar 31, 2017 $1.61M
Long Term Debt Q1 2018 · Mar 31, 2018 $522K
Long Term Debt Q1 2018 · Dec 31, 2017 $520K
Short Term Debt Q1 2018 · Mar 31, 2018 $105K
Short Term Debt Q1 2018 · Dec 31, 2017 $101K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $62.62M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $64.93M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $55.46M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $59.63M
Stockholders Equity Q1 2018 · Mar 31, 2018 $221.38M
Stockholders Equity Q1 2018 · Dec 31, 2017 $213.16M
Current Liabilities Q1 2018 · Mar 31, 2018 $46.46M
Current Liabilities Q1 2018 · Dec 31, 2017 $47.43M
Total Liabilities Q1 2018 · Mar 31, 2018 $112.47M
Total Liabilities Q1 2018 · Dec 31, 2017 $112.65M
Current Assets Q1 2018 · Mar 31, 2018 $163.22M
Current Assets Q1 2018 · Dec 31, 2017 $153.37M
Total Assets Q1 2018 · Mar 31, 2018 $333.96M
Total Assets Q1 2018 · Dec 31, 2017 $325.63M
Sga Expense Q1 2018 · Mar 31, 2018 $10.46M
Sga Expense Q1 2018 · Mar 31, 2017 $8.95M
Rd Expense Q1 2018 · Mar 31, 2018 $9.44M
Rd Expense Q1 2018 · Mar 31, 2017 $9.51M
Net Income Q1 2018 · Mar 31, 2018 −$1.46M
Net Income Q1 2018 · Mar 31, 2017 −$1.19M
Operating Income Q1 2018 · Mar 31, 2018 −$1.13M
Operating Income Q1 2018 · Mar 31, 2017 −$1.68M
Gross Profit Q1 2018 · Mar 31, 2018 $46.17M
Gross Profit Q1 2018 · Mar 31, 2017 $41.19M
Cost Of Revenue Q1 2018 · Mar 31, 2018 $61.13M
Cost Of Revenue Q1 2018 · Mar 31, 2017 $55.64M
Revenue Q1 2018 · Mar 31, 2018 $107.3M